Is this message not displayed correctly?
Please click here for the online version.
|
|
Dear Sir or Madam,
Great things happen when ideas, capital, and innovation come together – and Berlin is the place to make it happen.
Right now, something big is taking shape in the German capital: with bio:cap, the region is launching a new international event format that will help shape the future of life sciences. As the Health Industry Cluster, we’re proud to be part of this initiative and have signed a cooperation agreement with Messe Berlin – a strong signal for the location and the innovative strength of our networks.
Taking place for the first time from June 9 to 11, 2026, bio:cap is more than another trade fair: it’s an Investival – a platform that connects disruptive ideas from life sciences and artificial intelligence with capital and policy. Under the patronage of Charité and the Berlin Institute of Health (BIH), and supported by the Hasso Plattner Institute (HPI), this new format breaks down traditional industry boundaries and builds new alliances – between research, industry, investors, and policymakers.
Berlin is the ideal place for this. Our cluster brings together excellent science, dynamic start-ups, a growing AI scene, and international visibility. bio:cap connects life sciences, AI, and capital – right at the intersection where Berlin is particularly strong. As Host City Partner, we’re actively contributing our network and experience from the capital region’s health industry cluster.
To fully focus our efforts on bio:cap, we’ve decided to pause our popular premium format, the BIONNALE, in 2026. This was not an easy decision – we know how much many of you value the BIONNALE. But we’re convinced: bio:cap offers the opportunity to take our content, networks, and vision to a new international level. And we look forward to seeing many familiar faces there – in a new and inspiring setting.
Now it’s up to all of us to bring this new format to life. Let’s work together to make bio:cap a beacon of innovation and investment – for Berlin, for Europe, and for the health economy of tomorrow.
Warm regards,
Dr. Kai Bindseil
Berlin Partner for Business and Technology
|
|
Green Chemistry: the sustainable path to enhanced efficiency Fewer by-products, lower energy consumption, more sustainable materials, greater environmental protection, increased recyclability – these are just some of the goals of green chemistry. Making the chemical production of consumer goods and raw materials more environmentally friendly has been an important part of research for some time now. In the capital region, numerous players are dedicated to green chemistry and are researching, developing and producing in this field. |
|
|
Print rather than build – AMBER helps Berlin to become 3D printing capital Owing to the many advantages it offers, Additive Manufacturing, also known as 3D printing, currently is one of the most promising technologies. Therefore, promoting research and development in this area is an integral part of Berlin's industrial policy. Berlin wants to become Europe’s 3D printing capital by 2030. To realize this goal, Berlin Partner and associates such as TU Berlin, BAM, MGA and WVsC, founded AMBER, the 3D printing initiative of the capital region, in 2022. AMBER is financed by the Berliner Innovationsförderfonds (Berlin Innovation Fund) and supported by the Senate Department for Economic Affairs, Energy and Public Enterprises. Read more |
|
|
“Prevention and Patient Empowerment – Your Ideas for a Healthier Future” – The Barcamp Health Innovation for the Healthcare of Tomorrow In order to tackle the immense challenges posed by demographic change, we urgently need more prevention, both in society and in the healthcare system. But how can we achieve better prevention and patient empowerment? This question was addressed at the Barcamp Health Innovation 2025 in Berlin. Numerous stakeholders from the Berlin-Brandenburg metropolitan region presented their ideas and solutions and discussed possibilities for their further development and implementation. |
|
|
The tip from our relocation experts: Berlin offers a broad and diverse talent pool in the health and life sciences sector, supported by a strong academic landscape and a vibrant innovation culture. Each year, thousands of graduates from universities and applied science institutions enter the workforce, bringing expertise in biotechnology, medical technology, digital health, and related fields. |
|
|
The city’s international appeal also attracts professionals from across Europe and beyond, contributing to a multilingual and multidisciplinary environment that is particularly valuable for globally active companies.
One example of how Berlin is strengthening its innovation pipeline is the newly launched startup factory UNITE – Berlin-Brandenburg. This federally funded initiative brings together academic institutions, industry partners, and investors to support science-based startups in areas such as HealthTech, AI, and GreenTech. Networks like UNITE help ensure that research talent is not only retained in the region but also actively supported in transitioning into entrepreneurial roles.
Interested in building your team or connecting with local innovation networks? We’re happy to assist.
Flavia Kruse
Berlin Partner for Business and Technology
MedTech | Healthcare | Digital Health 📧
|
|
|
|
|
Berlin Bio Innovation Day
September 23, 2025 | Berlin, Germany
Read more |
|
SPARK-BIH & Global Meet up Venture Capital Day
October 1, 2025 | Berlin Germany
Read more |
|
World Health Summit 2025
October 12-14, 2025 | Berlin, Germany
Read more |
|
Current Topics in Bioinformatics: AI has arrived – but also intelligent systems?
October 13, 2025 | Berlin, Germany
This event is part of a ceremony conducted in German at Freie Universität Berlin
Read more |
|
BIO Europe
November 3-5, 2025 | Vienna, Austria
HealthCapital booth at German Pavilion
Read more |
|
Frontiers Health
November 11-12, 2025 | Berlin, Germany
Read more |
|
MEDICA 2025
November 17-20, 2025 | Düsseldorf, Germany
Read more |
|
ATMP-Workshop „The Product is the process, is it?“ Manufacturing and Translation of ATMP and Tissue-& Cell-based products
November 20, 2025 | Potsdam, Germany
Read more |
|
RegMed Forum 2026: clinical translation of advanced therapeutic approaches
February 19, 2026 | Berlin, Germany
Read more |
|
SAVE THE DATE: bio:cap International
Life Science and AI Investival
June 09-11, 2026 | Berlin, Germany
Read more |
|
For more events in the life science region Berlin-Brandenburg click here. |
|
Construction begins for the Berlin Center for Gene and Cell Therapies
A groundbreaking ceremony kicked off the construction work for the Berlin Center for Gene and Cell Therapies (BC GCT) – a project with the potential to make Berlin a hotspot for the development of innovative therapies. Bayer AG and Charité – Universitätsmedizin Berlin first presented their plans for the joint project in June last year. Construction officially began now in Berlin-Mitte alongside their new partner, the Berlin Institute of Health at Charité (BIH), in the presence of Federal Minister of Finance Lars Klingbeil and Kai Wegner, Governing Mayor of Berlin.
Read more |
|
Takeda Strengthens Berlin Site as Future German Headquarters
Takeda will relocate the headquarters of Takeda GmbH from Constance to Berlin by the end of 2028. The company will focus its future operations on three key sites: Berlin, and the manufacturing facilities in Oranienburg and Singen. Employees in Constance were informed today about the planned changes.
Read more |
|
A first-in-human feasibility study to evaluate the safety of the autologous GrOwnValve transcatheter pulmonary heart valve
In the GECT-DZHK28 study of the German Center for Cardiovascular Research, scientists are investigating a heart valve replacement made of the patient's own tissue in humans, which is unique worldwide according to the current state of knowledge. The aim is to obtain safe implants that will last a lifetime, if possible..
Read more |
|
BIOTRONIK and CardioFocus Partner to Expand Pulsed Field Ablation Access in Europe
BIOTRONIK, a global leader in medical technology, announced a strategic distribution agreement with CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias. BIOTRONIK will serve as the exclusive distributor of the Centauri™ Pulsed Field Ablation (PFA) System in selected European countries. This collaboration represents a significant milestone in the commercial expansion of Centauri — a next generation focal PFA system that provides physicians with highly controllable and versatile solution for cardiac ablation in the treatment of paroxysmal atrial fibrillation.
Read more |
|
AssistMe secures €5.2 million in growth capital for its care platform alea
Read more |
|
Preventive medicine: Charité and Siemens Healthineers jointly develop innovative concepts
Read more |
|
Volkswagen Foundation to provide more than 1.1 million euros of funding for neurobiology research project at Freie Universität Berlin
Read more |
|
Labor Berlin among Germany’s innovation champions for the fourth time
Read more |
|
Science and Technology News
|
|
|
Charité study in Nature uncovers fundamental processes in the fly brain Flies too need their sleep. In order to be able to react to dangers, however, they must not completely phase out the environment. Researchers at Charité – Universitätsmedizin Berlin have now deciphered how the animal's brain produces this state. As they describe in the journal Nature*, the fly brain filters out visual information rhythmically during sleep – so that strong visual stimuli could still wake the animal up. |
|
|
NLRP3 as a driver of inflammation in common diseases
Prof. Dr. Eicke Latz, Scientific Director of the German Rheumatology Research Center, a Leibniz-Institute, together with colleagues who have been researching the role of the NLRP3 molecule for many years, has published a review article in the journal Nature Immunology. The article summarizes the current state of knowledge about this key driver of many common diseases, including atherosclerosis, Alzheimer’s disease, and gout.
Read more |
|
New Insights into Tamoxifen Side Effects
An international research team bringing together Prof. Kirsten Kübler from the Berlin Institute of Health at Charité (BIH), and colleagues from Broad Institute of MIT and Harvard, Mass General Brigham and Dana-Farber Cancer Institute has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can increase the risk of secondary tumors in the uterus.
Read more |
|
Biomarkers for Brain Insulin Resistance Discovered in the Blood
Read more |
|
Simulations of large biomolecules with quantum accuracy
Read more |
|
“Nature Machine Intelligence” Study: Language Models from Artificial Intelligence Can Predict How the Human Brain Responds to Visual Stimuli
Read more |
|
Qanatpharma, Zuse Institute Berlin, Enamine, and Proteros biostructures Announce Generative-AI Driven Lead Discovery Collaboration
Read more |
|
Personalized treatment for peanut allergy
Read more |
|
Technology and Cooperation Offers
|
|
|
Injection tunnel for stress-reduced handling of laboratory mice
Read more |
|
Activity-enhanced variant of hyperactive Sleeping Beauty transposase SB100X
Read more |
|
For more news from the cluster healthcare industries click here. |
|
EDITOR | IMPRINT
This newsletter is operated by the cluster healthcare industries
Berlin-Brandenburg HealthCapital.
Berlin Partner for Business and TechnologyFasanenstrasse 85 | 10623 Berlin | GermanyPhone: +49 30 46302-463Email: healthcapital@berlin-partner.de
Commercial Registry Entry
Entered in the commercial registry of the Charlottenburg District Court,
Registration number: HRB 13072 B
VAT ID: DE 136629780
CEO: Dr. Stefan Franzke
Chairman of the Supervisory Board: Carsten Jung
Editorial: In cooperation with dpa-Custom Content.
Responsible body in terms of German Press LawCarolin Meltendorf, Press Spokeswoman Berlin Partner for Business and Technology© 2025 Berlin Partner for Business and Technology |
|
The newsletter of the Cluster healthcare industries Berlin-Brandenburg is a project of Berlin Partner for Business and Technology.
|
|
|
You have been forwarded this newsletter and would like to subscribe?
Please click here.You want to unsubscribe from the newsletter (to: unknown@noemail.com)? Please click here.
|
|
|
|
|
